title: Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes.
abstract: BACKGROUND
  We present cytogenetics and fibroblast growth factor immunohistochemistry in one case of cystosarcoma phyllodes with localized disease and one with metastatic spread. The p53 gene was sequenced in the malignant case.
  
  
  RESULTS
  Karyotype analysis used trypsin-Giemsa banding. Immunohistochemistry of FGF1, FGF2, FGFR1 and p53 used avidin-biotin detection of the primary antibody. One case had a mosaic female karyotype and three clones: one normal, one with trisomy 7, and one with both trisomy 5 and a rearranged chromosome 1. In the second case, a resected pulmonary metastasis had the karyotype 43-47,XX,+mar1,+mar2[6]/43-46,XX, +del(7)(p10)[3],+mar2[1][cp3]/46,XX[10]. These tumors expressed FGF1, FGF2, and FGFR1. The malignant case showed immunostaining for p53 protein, but a wild-type gene sequence.
  
  
  CONCLUSIONS
  The karyotype of cystosarcoma phyllodes is complex, with wide case-to-case variation. These tumors express members of the FGF family. Metastatic behavior can occur in the presence of a wild-type p53 gene.
authors.affiliation: Laurel Highlands Cancer Program, Conemaugh Memorial Medical Center and Lee Hospital, Johnstown, PA 15901, USA. wooleypv@msx.upmc.edu
authors.forename: P V
authors.initials: PV
authors.lastname: Woolley
authors.forename: S M
authors.initials: SM
authors.lastname: Gollin
authors.forename: W
authors.initials: W
authors.lastname: Riskalla
authors.forename: S
authors.initials: S
authors.lastname: Finkelstein
authors.forename: D F
authors.initials: DF
authors.lastname: Stefanik
authors.forename: L
authors.initials: L
authors.lastname: Riskalla
authors.forename: W P
authors.initials: WP
authors.lastname: Swaney
authors.forename: L
authors.initials: L
authors.lastname: Weisenthal
authors.forename: R J
authors.initials: RJ
authors.lastname: McKenna
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000648:ultrastructure*; D005260:Female; D005346:Fibroblast Growth Factors / Q000032:analysis*; D016158:Genes, p53; D006801:Humans; D007150:Immunohistochemistry; D007621:Karyotyping; D008175:Lung Neoplasms / Q000556:secondary; D008875:Middle Aged; D003557:Phyllodes Tumor / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism / Q000556:secondary; D013194:Staining and Labeling; D014178:Translocation, Genetic
chemical_list: D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D005346:Fibroblast Growth Factors